News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Emergent BioSolutions
NEWS
JOBS
IN THE PRESS
NEWS
Business
Drugmakers Like Johnson & Johnson, Emergent BioSolutions, And Mapp Biopharmaceutical Stand To Gain Ebola Contracts Worth $2 Billion
November 11, 2014
·
1 min read
Biotech Beach
The Day In Review: BioSimilar Drug Enters Trial
March 21, 2007
·
1 min read
Biotech Beach
The Day In Review: Allergan Inc. Expands Obesity Franchise
February 23, 2007
·
1 min read
Deals
IPO Watch: Emergent BioSolutions Makes Anthrax Vaccine
November 16, 2006
·
1 min read
Biotech Beach
The Week In Review: Strong Gain; Stronger Breadth
August 21, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Emergent BioSolutions Announces CEO Transition
June 27, 2023
·
6 min read
BioCapital
Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic
May 15, 2023
·
3 min read
BioCapital
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT
May 11, 2023
·
1 min read
Business
Emergent BioSolutions Reports Financial Results For First Quarter 2023
May 9, 2023
·
28 min read
Business
Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023
April 19, 2023
·
1 min read
FDA
U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
March 29, 2023
·
5 min read
Business
Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022
February 27, 2023
·
36 min read
BioCapital
Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use
February 15, 2023
·
8 min read
Deals
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
February 15, 2023
·
6 min read
Deals
Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions
February 15, 2023
·
7 min read
